<?xml version="1.0" encoding="UTF-8"?>
<GaPExchange xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="./dbGaPEx2.1.5.xsd">

<MetaVariables>
	<Submitter/>
	<Method/>
</MetaVariables>
<MetaLinks/>

<Projects>
	<Project/>
</Projects>

<Studies>

<Study source="dbGaP" accession="phs000952.v1.p1" parentStudy="phs000952.v1.p1" createDate="2015-07-10" modDate="2016-03-09">

<Configuration>
	<Data_Provider><![CDATA[
		<table border="1">
		<tr><th>Title</th><th>Name</th><th>Institute</th></tr>
		<tr><td>Principal Investigator</td><td>Joel Gelernter, MD</td><td>Yale University School of Medicine, New Haven, CT, USA</td></tr>
		<tr><td>Co-Principal Investigator</td><td>Henry R. Kranzler, MD</td><td>University of Pennsylvania School of Medicine, Philadelphia, PA, USA</td></tr>
		<tr><td>Funding Sources</td><td>Genetics of Opioid Dependence</td><td>National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, USA</td></tr>
		<tr><td>Funding Sources</td><td>Genome-Wide Study of Cocaine Dependence in Two Populations</td><td>National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, USA</td></tr>
		</table>
	]]></Data_Provider>
	<StudyNameEntrez>Substance Dependence GWAS in European- and African - Americans</StudyNameEntrez>
	<StudyNameReportPage>Substance Dependence GWAS in European- and African - Americans</StudyNameReportPage>
	<StudyTypes>
		<StudyType>Case-Control</StudyType>
		<StudyType>Family</StudyType>
	</StudyTypes>
	<Description><![CDATA[
<p>This study includes SSADDA (Semi Structured Assessment for Drug Dependence and Alcoholism) assessed subjects (mostly unrelated, but including some affected sibling pairs) recruited in the course of several substance dependence genetics projects. The sample includes 1,531 self-reported African-American (AA) subjects, 1,339 self-reported European-American (EA) subjects, and 2 who reported race as "unknown" or "missing".</p>]]>
	</Description>
	<StudyInEx><![CDATA[
<p>Affected subjects were included on the basis of meeting DSM-IV criteria for opioid, cocaine, or alcohol dependence. Schizophrenia, bipolar affective disorder, or other major psychotic illness, and gross cognitive impairment were exclusion criteria in probands, although siblings of probands with these disorders were enrolled.</p>]]>
	</StudyInEx>
	<StudyProjects>
		<Project/>
	</StudyProjects>
	<Publications>
		<Publication>
			<Pubmed pmid="15909294"/>
		</Publication>
		<Publication>
			<Pubmed pmid="15896927"/>
		</Publication>
		<Publication>
			<Pubmed pmid="16642432"/>
		</Publication>
		<Publication>
			<Pubmed pmid="17081504"/>
		</Publication>
		<Publication>
			<Pubmed pmid="17582692"/>
		</Publication>
		<Publication>
			<Pubmed pmid="18930185"/>
		</Publication>
		<Publication>
			<Pubmed pmid="20147890"/>
		</Publication>
		<Publication>
			<Pubmed pmid="20485328"/>
		</Publication>
		<Publication>
			<Pubmed pmid="22520967"/>
		</Publication>
		<Publication>
			<Pubmed pmid="23958962"/>
		</Publication>
		<Publication>
			<Pubmed pmid="24143882"/>
		</Publication>
		<Publication>
			<Pubmed pmid="24166409"/>
		</Publication>
		<Publication>
			<Pubmed pmid="25345593"/>
		</Publication>
		<Publication>
			<Pubmed pmid="25555482"/>
		</Publication>
	</Publications>
	<Diseases>
		<Disease vocab_source="MESH" vocab_term="Substance-Related Disorders"/>
		<Disease vocab_source="MESH" vocab_term="Cocaine-Related Disorders"/>
		<Disease vocab_source="MESH" vocab_term="Tobacco Use Disorder"/>
		<Disease vocab_source="MESH" vocab_term="Opioid-Related Disorders"/>
		<Disease vocab_source="MESH" vocab_term="Alcohol-Related Disorders"/>
	</Diseases>
	<Attributions>
		<Header title="Principal Investigator">
			<AttName>Joel Gelernter, MD</AttName>
			<Institution>Yale University School of Medicine, New Haven, CT, USA</Institution>
		</Header>
		<Header title="Co-Principal Investigator">
			<AttName>Henry R. Kranzler, MD</AttName>
			<Institution>University of Pennsylvania School of Medicine, Philadelphia, PA, USA</Institution>
		</Header>
		<Header title="Funding Sources">
			<AttName>Genetics of Opioid Dependence</AttName>
			<Institution>National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Funding Sources">
			<AttName>Genome-Wide Study of Cocaine Dependence in Two Populations</AttName>
			<Institution>National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
	</Attributions>
	<DisplayPublicSummary>yes</DisplayPublicSummary>
	<StudyHistory><![CDATA[
<p>This sample was collected in the course of three projects: studies focused on alcohol dependence genetics, and studies focused on cocaine and opioid dependence genetics. In the early stages of these studies, affected sibling pairs suitable for linkage analysis were collected, and a relatively small number of these families are included in the present sample. This sample and other overlapping and sub-samples were the basis of published linkage studies on alcohol, cocaine, opioid, and nicotine dependence; and GWAS studies of cocaine, opioid, alcohol, and nicotine dependence, as well as a "submitted" GWAS of cannabis dependence.</p>]]>
	</StudyHistory>
	<ConsentGroups>
		<ConsentGroup groupNum="0" shortName="NRUP" longName="Subjects did not participate in the study, did not complete a consent document and are included only for the pedigree structure and/or genotype controls, such as HapMap subjects"/>
		<ConsentGroup groupNum="1" shortName="DS-ADX-IRB-RD" longName="Disease-Specific (Addictive Disorders, IRB, RD)"/>
	</ConsentGroups>
</Configuration>

  <AuthorizedAccess>
    <DacInfo ssDacId="0">
      <DacName>NIDA</DacName>
      <DacFullName>NIDA</DacFullName>
      <DacEmail>0</DacEmail>
      <DacPhone></DacPhone>
      <DacUrl></DacUrl>
    </DacInfo>
    <Policy Policy_ID="phs000952.v1.p1_policy" ref_ssDacId="0">
      <DisplayResearchStatement>yes</DisplayResearchStatement>
      <DisplayPublicSummary>yes</DisplayPublicSummary>
      <EmbargoLength>12</EmbargoLength>
      <YearsUntilRenewal>1</YearsUntilRenewal>
      <WeeksCancelRequest>8</WeeksCancelRequest>
      <PdfSupplementReqired>yes</PdfSupplementReqired>
      <AcknowledgementText>
        <para>
          http://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000952.v1.p1
        </para>
      </AcknowledgementText>
      <DocumentSet>
        <DataUseCertificate Label="Data Use Certificate" FilePath="https://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000952.v1.p1" FileName=""/>
      </DocumentSet>
    </Policy>
    <ConsentGroups>
      <ParticipantSet groupNum-REF="1">
        <ConsentName>Disease-Specific (Addictive Disorders, IRB, RD)</ConsentName>
        <ConsentAbbrev>DS-ADX-IRB-RD</ConsentAbbrev>
        <UseLimitation>Use of the data must be related to Addictive Disorders and related disorders.
Requestor must provide documentation of local IRB approval.
Subjects consented to research on addictive disorders and related traits.</UseLimitation>
        <IrbRequired>Yes</IrbRequired>
      </ParticipantSet>
    </ConsentGroups>
  </AuthorizedAccess>


</Study>

</Studies>

</GaPExchange>
